Clinovo Presents Next Generation Cloud-Based eClinical System At Venture Capital Conference

Clinovo will present its vision for CloudClinica, the next generation cloud-based platform for clinical trials, at the 30th Annual Investors Choice Venture Capital Conference on Thursday, February 6th in Salt Lake City, Utah.

Sunnyvale, CA (PRWEB) February 05, 2014

Clinovo is a technology focused Contract Research Organization (CRO) headquartered in Sunnyvale, CA. Clinovo is seeking funds to launch CloudClinica, a disruptive cloud-based platform for clinical trials. Ale Gicqueau, President & CEO at Clinovo, will present his vision and strategy for CloudClinica to venture capitalists at the 30th Annual Investors Choice Venture Capital Conference. The event will be held on Thursday, February 6th in Salt Lake City, Utah.

The Annual Investors Choice Venture Capital Conference is organized by the Wayne Brown Institute (WBI). Venture capitalists from all over the United States will convene to learn about the best and brightest emerging IT and life science companies. In the last six years, technology start-ups that have gone through the Wayne Brown Institute (WBI) process have raised more than $632 million dollars in angel and venture capital. Clinovo will present CloudClinica among twenty innovative companies from the high-tech, life-science and clean-tech sectors.

CloudClinica is Clinovo’s next generation Cloud-based eClinical platform. CloudClinica is an easy-to-use, pay-as-you-go platform to build and manage clinical studies from the ground up without any programming skills. CloudClinica will remove IT dependency and allow small companies to access sophisticated eClinical systems. CloudClinica will bring an average 80% savings from existing solutions while meeting regulatory compliance requirements. Until today, the adoption of eClinical systems like EDC (Electronic Data Capture) has remained slow in some segments of clinical research. Only 40% of Phase I clinical trials had adopted EDC by the end of 2012. CloudClinica will broaden the use of eClinical systems and empower biotech, pharmaceutical, medical device, and diagnostic companies.

Clinovo is a pioneer in the field of eClinical systems with its advanced open source Electronic Data Capture (EDC) system ClinCapture. ClinCapture has been deployed in phase I to phase IV clinical studies, for pharmaceutical, medical device, diagnostic companies, and CROs. ClinCapture already features an integrated eClinical suite of modules, including easy-to-use randomization, ePRO (Patient Reported Outcomes), CTMS (Clinical Trials Management System), and offline data entry. Clinovo recently unveiled its new medical coding module at the Outsourcing in Clinical Trials West Coast Conference in Burlingame, CA, greatly improving clinical data consistency and interoperability.

Contact information
Sophie McCallum
Director of Operations, Clinovo
408-773-6258
sophie.mccallum(at)clinovo(dot)com

About Clinovo
Clinovo is a technology focused Contract Research Organization (CRO) headquartered in the Silicon Valley. Clinovo streamlines clinical trials for life science companies globally by developing validated, intuitive open source eClinical systems. Clients claim over 50% cost savings using Clinovo’s open source Electronic Data Capture (EDC) system ClinCapture, and CDISC Express, the first open source CDISC conversion tool. Services also include Biometrics Services, Staffing Solutions, and TechTrainings.